Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
National Drug Code and coverage policies (where applicable)
Similar content being viewed by others Introduction Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of drugs developed initially for treatment of type 2 diabetes (T2D) and then obesity, by mimicking the incretin effect which includes glucose-dependent increased insulin secretion and improved glycaemic control, and inducing weight loss in a dose-dependent manner [1]
19 West, D
True Resistance vs Perceived Stalls Distinguishing between genuine medication resistance and a perceived stall requires understanding what resistance would look like pharmacologically
US$ 29.16
US$ 23.14
US$ 22.87
US$ 22.42
US$ 28.09
